Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Similarities and Differences in 111In- and 90Y-Labeled 1B4M-DTPA AntiTac Monoclonal Antibody Distribution

Jorge A. Carrasquillo, J. D. White, Chang H. Paik, Andrew Raubitschek, Nhat Le, Mark Rotman, Martin W. Brechbiel, Otto A. Gansow, Lois E. Top, Patricia Perentesis, James C. Reynolds, David L. Nelson and Thomas A. Waldmann
Journal of Nuclear Medicine February 1999, 40 (2) 268-276;
Jorge A. Carrasquillo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. D. White
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang H. Paik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Raubitschek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nhat Le
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Rotman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin W. Brechbiel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto A. Gansow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lois E. Top
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Perentesis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James C. Reynolds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L. Nelson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Waldmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 2 268-276
PubMed 
10025834

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT© 1999 by the Society of Nuclear Medicine, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 89 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2001 to April 2025

AbstractFullPdf
Mar 2001100
Apr 2001200
Oct 2001600
Nov 2001500
Dec 2001200
Jan 2002100
Feb 2002100
Mar 2002100
Oct 2002300
Nov 2002400
Jan 2003300
Feb 2003100
Mar 2003201
Apr 2003101
May 2003100
Jun 2003202
Jul 2003502
Aug 2003800
Sep 20031004
Oct 2003900
Nov 2003700
Dec 2003501
Jan 2004600
Feb 20041007
Mar 2004803
Apr 2004600
May 2004804
Jun 20042003
Jul 20042100
Aug 2004902
Sep 2004801
Oct 2004702
Nov 2004801
Dec 2004801
Jan 20051503
Feb 20051000
Mar 2005901
Apr 2005702
May 2005201
Jun 20051103
Jul 2005200
Aug 2005400
Sep 2005603
Oct 2005303
Nov 2005300
Dec 2005500
Jan 2006901
Feb 2006300
Mar 2006402
Apr 2006100
May 2006402
Jun 20061003
Jul 2006100
Aug 2006400
Sep 20061508
Oct 2006901
Nov 2006403
Dec 2006101
Jan 20079015
Feb 20077010
Mar 2007602
Apr 2007409
May 2007807
Jun 2007604
Jul 2007200
Aug 20078010
Sep 2007707
Oct 2007708
Nov 20078014
Dec 2007301
Jan 2008503
Feb 2008107
Mar 2008606
Apr 2008509
May 2008508
Jun 2008508
Jul 2008505
Aug 2008504
Sep 2008603
Oct 2008105
Nov 2008107
Dec 2008304
Jan 2009307
Feb 2009409
Mar 20092010
Apr 20092010
May 2009302
Jun 2009806
Jul 20095011
Aug 2009408
Sep 2009507
Oct 2009608
Nov 2009403
Dec 2009002
Jan 2010606
Feb 2010004
Mar 2010501
Apr 2010302
May 2010404
Jun 20105013
Jul 2010206
Aug 2010105
Sep 2010604
Oct 2010306
Nov 201010017
Dec 20101308
Jan 2011302
Feb 2011402
Mar 2011508
Apr 2011609
May 2011709
Jun 2011006
Jul 20110012
Aug 2011009
Sep 20110013
Oct 20110015
Nov 2011006
Dec 20110013
Jan 2012004
Feb 20120014
Mar 20120010
Apr 2012009
May 2012007
Jun 2012003
Jul 20120010
Aug 2012003
Sep 2012001
Oct 2012006
Nov 2012007
Dec 20120012
Jan 2013006
Feb 2013006
Mar 20130012
Apr 20130021
May 20130017
Jun 2013001
Jul 2013003
Aug 2013005
Sep 2013003
Oct 2013007
Nov 2013001
Dec 2013001
Jan 2014004
Feb 2014006
Mar 2014006
Apr 2014005
May 2014001
Jun 2014004
Jul 2014002
Aug 2014006
Sep 2014004
Oct 2014003
Nov 20140011
Dec 2014004
Jan 2015004
Feb 20150010
Mar 2015009
Apr 2015004
May 2015005
Jun 20150010
Jul 20150013
Aug 2015005
Sep 2015006
Oct 2015001
Nov 2015003
Dec 20150012
Jan 2016009
Feb 2016008
Mar 20160015
Apr 2016005
May 2016006
Jun 2016005
Jul 20160016
Aug 20160010
Sep 2016007
Oct 20160015
Nov 2016019
Dec 2016005
Jan 2017005
Feb 2017006
Mar 2017006
Apr 2017004
May 2017003
Jul 2017003
Aug 2017002
Sep 2017003
Oct 2017004
Nov 2017008
Dec 2017001
Jan 2018003
Feb 2018009
Mar 2018005
Apr 2018003
May 2018003
Jun 2018003
Jul 2018001
Sep 2018004
Oct 20180011
Nov 2018004
Jan 2019001
Feb 2019004
Mar 2019001
Apr 2019003
May 2019004
Jun 2019001
Jul 2019007
Sep 2019001
Oct 2019002
Dec 2019004
Jan 2020002
Feb 2020002
Mar 2020007
Apr 2020001
May 2020003
Jun 2020004
Jul 2020004
Aug 2020003
Sep 2020001
Oct 2020004
Nov 2020003
Dec 2020002
Jan 2021002
Feb 2021203
Mar 2021205
Apr 2021205
May 2021405
Jun 2021103
Jul 2021005
Aug 2021102
Sep 2021100
Oct 2021001
Nov 20211010
Jan 2022107
Feb 2022201
Mar 2022103
Apr 2022002
May 2022009
Jun 20220011
Jul 20225012
Aug 2022206
Sep 2022103
Oct 2022101
Nov 2022003
Dec 2022009
Jan 2023106
Feb 2023202
Mar 2023006
Apr 2023006
May 2023006
Jun 2023001
Jul 2023009
Aug 2023207
Sep 2023102
Oct 2023206
Nov 2023105
Dec 2023109
Jan 2024002
Feb 2024003
Mar 2024100
Apr 2024007
May 2024006
Jun 2024003
Jul 2024106
Aug 2024008
Sep 20240010
Oct 2024006
Nov 2024103
Dec 2024005
Jan 20251022
Feb 2025409
Mar 2025005
Apr 2025109
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 2
February 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Similarities and Differences in 111In- and 90Y-Labeled 1B4M-DTPA AntiTac Monoclonal Antibody Distribution
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Similarities and Differences in 111In- and 90Y-Labeled 1B4M-DTPA AntiTac Monoclonal Antibody Distribution
Jorge A. Carrasquillo, J. D. White, Chang H. Paik, Andrew Raubitschek, Nhat Le, Mark Rotman, Martin W. Brechbiel, Otto A. Gansow, Lois E. Top, Patricia Perentesis, James C. Reynolds, David L. Nelson, Thomas A. Waldmann
Journal of Nuclear Medicine Feb 1999, 40 (2) 268-276;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Similarities and Differences in 111In- and 90Y-Labeled 1B4M-DTPA AntiTac Monoclonal Antibody Distribution
Jorge A. Carrasquillo, J. D. White, Chang H. Paik, Andrew Raubitschek, Nhat Le, Mark Rotman, Martin W. Brechbiel, Otto A. Gansow, Lois E. Top, Patricia Perentesis, James C. Reynolds, David L. Nelson, Thomas A. Waldmann
Journal of Nuclear Medicine Feb 1999, 40 (2) 268-276;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma
  • Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model
  • A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma
  • Radioimmunotherapy of Breast Cancer Metastases with {alpha}-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
  • Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma
  • 203Pb-Labeled {alpha}-Melanocyte-Stimulating Hormone Peptide as an Imaging Probe for Melanoma Detection
  • Toward Patient-Friendly Cell-Level Dosimetry
  • Radioimmunotherapy of CD22-Expressing Daudi Tumors in Nude Mice with a 90Y-Labeled Anti-CD22 Monoclonal Antibody
  • 89Zr as a PET Surrogate Radioisotope for Scouting Biodistribution of the Therapeutic Radiometals 90Y and 177Lu in Tumor-Bearing Nude Mice After Coupling to the Internalizing Antibody Cetuximab
  • Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer
  • Planning Time for Peripheral Blood Stem Cell Infusion After High-Dose Targeted Radionuclide Therapy Using Dosimetry
  • Pharmacokinetics and Biodistribution of 111In- and 177Lu-Labeled J591 Antibody Specific for Prostate-Specific Membrane Antigen: Prediction of 90Y-J591 Radiation Dosimetry Based on 111In or 177Lu?
  • Quantitative 89Zr Immuno-PET for In Vivo Scouting of 90Y-Labeled Monoclonal Antibodies in Xenograft-Bearing Nude Mice
  • Radiolabeled Monoclonal Antibodies Specific to the Extracellular Domain of Prostate-Specific Membrane Antigen: Preclinical Studies in Nude Mice Bearing LNCaP Human Prostate Tumor
  • 90Y-DOTA-hLL2: An Agent for Radioimmunotherapy of Non-Hodgkin's Lymphoma
  • Radiolabeled Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoma
  • Comparative Cellular Catabolism and Retention of Astatine-, Bismuth-, and Lead-Radiolabeled Internalizing Monoclonal Antibody
  • Metabolite Production in Patients with Lymphoma After Radiometal-Labeled Antibody Administration
  • PET Imaging for Planning Cancer Therapy
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire